异动解读 | 科济药业-B(02171)盘中大涨20.7% 涨幅领先同行业股

异动解读
27 Nov 2024

科济药业-B(02171)股价今日盘中大涨20.7%,引起市场广泛关注。从相关新闻报道来看,此次股价大涨主要源于交投活跃带来的股价波动。

消息显示,科济药业-B早盘9:30较前收市价即上升5.248%至7.22港元。之后该股持续上涨,截至上午9:31,股价已涨至7.25港元,涨幅达5.69%,成交量39.65万股。同时资金呈现净流入格局,流入181.284万港元,高于流出67.46万港元。

作为创新CAR-T细胞治疗公司,科济药业-B近期财报显示营收694.66万港元,净利润亏损3.85亿港元。尽管亏损持续,但机构给予积极评级,四家券商中有一半看好其前景,发出"买入"评级。在生物技术行业整体上涨0.24%的背景下,科济药业-B的涨幅明显领先同行业股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10